Schizophrenia
9 competing products in clinical development for Schizophrenia.
Pipeline by Phase
Pre-clinical1
Phase 22
Phase 31
Approved5
All Products (9)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Olanzapine + Aripiprazole | Eli Lilly | Approved | Completed | 85 |
| olanzapine therapy | Eli Lilly | Approved | Completed | 85 |
| Clozapine + Olanzapine | Eli Lilly | Approved | Completed | 85 |
| Atomoxetine | Eli Lilly | Approved | Completed | 85 |
| Olanzapine + olanzapine + risperidone | Eli Lilly | Approved | Completed | 85 |
| Olanzapine + Placebo | Eli Lilly | Phase 3 | Completed | 77 |
| olanzapine-RAIM + placebo | Eli Lilly | Phase 2 | Completed | 52 |
| Risperidone + Placebo + LY2140023 | Eli Lilly | Phase 2 | Completed | 52 |
| antipsychotic dose increase | Eli Lilly | Pre-clinical | Completed | 23 |